Machine learning to detect recent recreational drug use in intensive cardiac care units.

Journal: Archives of cardiovascular diseases
PMID:

Abstract

BACKGROUND: Although recreational drug use is a strong risk factor for acute cardiovascular events, systematic testing is currently not performed in patients admitted to intensive cardiac care units, with a risk of underdetection. To address this issue, machine learning methods could assist in the detection of recreational drug use.

Authors

  • Nathan El Bèze
    Inserm MASCOT - UMRS 942, Department of Cardiology, University Hospital of Lariboisière, Université Paris-Cité, AP-HP, 75010 Paris, France; Multimodality Imaging Research for Analysis Core Laboratory: Artificial Intelligence (MIRACL.ai), Department of Data Science, Machine Learning and Artificial Intelligence in Health, University Hospital of Lariboisière, AP-HP, 75010 Paris, France.
  • Kenza Hamzi
    MIRACL.ai Laboratory, Multimodality Imaging for Research and Analysis Core Laboratory and Artificial Intelligence, University Hospital of Lariboisiere (AP-HP), Paris, France.
  • Patrick Henry
    Cardiology Department, Lariboisière Hospital, Assistance Publique Hôpitaux de Paris, Université Paris VII Denis Diderot, Paris, France.
  • Antonin Trimaille
    Department of Cardiovascular Medicine, Nouvel Hôpital Civil, Strasbourg University Hospital, Strasbourg, France.
  • Amine El Ouahidi
    Department of Cardiology, University Hospital of Brest, 29609 Brest, France.
  • Cyril Zakine
    NCT+, 37540 Saint-Cyr-sur-Loire, France.
  • Olivier Nallet
    Department of Cardiology, Hôpital Montfermeil, 93370 Montfermeil, France.
  • Clément Delmas
    Department of Cardiology, Rangueil University Hospital, Toulouse, France.
  • Victor Aboyans
    Department of Cardiology, University Hospital of Limoges, 87000 Limoges, France.
  • Marc Goralski
    Department of Cardiology, Centre Hospitalier d'Orléans, 45100 Orléans, France.
  • Franck Albert
    Department of Cardiology, Centre Hospitalier de Chartres, 28630 Le Coudray, France.
  • Eric Bonnefoy-Cudraz
    Intensive Cardiological Care Division, Louis-Pradel Hospital, Hospices Civils de Lyon, 69500 Bron, France.
  • Thomas Bochaton
    Intensive Cardiological Care Division, Louis-Pradel Hospital, Hospices Civils de Lyon, 69500 Bron, France.
  • Guillaume Schurtz
    Heart and Lung Institute, University hospital of Lille, Lille, France; FACT (French Alliance for Cardiovascular Trials), Paris, France.
  • Pascal Lim
    Intensive Cardiac Care Unit, Henri-Mondor University Hospital, 94000 Créteil, France.
  • Antoine Lequipar
    Inserm MASCOT - UMRS 942, Department of Cardiology, University Hospital of Lariboisière, Université Paris-Cité, AP-HP, 75010 Paris, France; Multimodality Imaging Research for Analysis Core Laboratory: Artificial Intelligence (MIRACL.ai), Department of Data Science, Machine Learning and Artificial Intelligence in Health, University Hospital of Lariboisière, AP-HP, 75010 Paris, France.
  • Trecy Gonçalves
    Department of Cardiology, Université Paris Cité, University Hospital of Lariboisiere, (Assistance Publique des Hôpitaux de Paris, AP-HP), 75010 Paris, France.
  • Emmanuel Gall
    Department of Cardiology, Université Paris Cité, University Hospital of Lariboisiere, (Assistance Publique des Hôpitaux de Paris, AP-HP), 75010 Paris, France.
  • Thibaut Pommier
    Department of Cardiology, University Hospital of Dijon, Dijon, France.
  • Léo Lemarchand
    Department of Cardiology and Vascular Diseases, CHU of Rennes, 35000 Rennes, France.
  • Christophe Meune
    Department of Cardiology, Hôpital Avicenne, AP-HP, 93000 Bobigny, France.
  • Sonia Azzakani
    Department of Cardiology, Clinical Investigation Centre (Inserm 1204), University Hospital of Poitiers, 86000 Poitiers, France.
  • Claire Bouleti
    Department of Cardiology, University Hospital of Poitiers, Poitiers, France.
  • Jonas Amar
    Department of Anesthesiology, Perioperative & Pain Medicine, Stanford University, Stanford, CA, USA.
  • Jean-Guillaume Dillinger
    MIRACL.ai Laboratory, Multimodality Imaging for Research and Analysis Core Laboratory and Artificial Intelligence, University Hospital of Lariboisiere (AP-HP), Paris, France; Université Paris Cité, Service de Cardiologie, Hôpital Lariboisière-Assistance Publique des Hôpitaux de Paris (APHP), Inserm UMRS 942, Paris, France.
  • P Gabriel Steg
    Inserm_U1148/LVTS, hôpital Bichat, université Paris-Cité, AP-HP, 75877 Paris, France.
  • Eric Vicaut
    Clinical Reasearch Unit, Hôpitaux Saint Louis-Lariboisière-Fernand Widal, AP-HP, University Paris Cité, Paris, France.
  • Solenn Toupin
    Siemens Healthcare France, Scientific Partnerships, Saint-Denis, France.
  • Théo Pezel
    Department of Cardiology, University Hospital of Lariboisiere, Université Paris-Cité, (Assistance Publique des Hôpitaux de Paris, AP-HP), Paris, France.